Replies to post #2888 on BioPharmX Corp fka BPMX

[PNW_Ironman]

In connection with the Merger, BioPharmX intends to file a Form S-4 registration statement with the U.S. Securities and Exchange Commission (“SEC”) that will contain a prospectus to register the BioPharmX shares to be issued to Timber's members in the Merger and a proxy statement for use in connection with the special meeting of BioPharmX stockholders that will be called to consider and vote upon the Merger and related matters. Further, the Form S-4 registration statement will describe a proposed reverse stock split of the post-Merger outstanding common stock of BioPharmX (in a ratio to be determined), which shall also be subject to approval by the BioPharmX stockholders at the special stockholders' meeting.


Go to otcmarkets.com and search BPMX, click on “disclosure” and scroll down to the SEC filings from this week.... 8-k and 425. It’s all there.